Cincinnati Financial (CINF) 75.70 $CINF Shares of CINF

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 7:16 AM

Cincinnati Financial (CINF) 75.70 $CINF

Shares of CINF Up 30.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 07, 12:29AM CDT
SmarTrend identified an Uptrend for Cincinnati Financial (NASDAQ:CINF) on February 1st, 2016 at $57.61. In approximately 5 months, Cincinnati Financial has returned 30.22% as of today's recent price of $75.02.
CINF: 75.70 (+0.73)

Nasdaq: Growth Prospects Bright, Escalating Expenses a Drag
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 8:03AM CDT
On Jun 30, 2016, we updated a research report on Nasdaq, Inc. (NDAQ).
CINF: 75.70 (+0.73), NDAQ: 65.88 (+0.96), BATS: 25.88 (+0.72), MKL: 947.53 (+15.23)

25.6% Return Seen to Date on SmarTrend Cincinnati Financial Call (CINF)
Comtex SmarTrend(R) - Wed Jun 29, 1:02PM CDT
SmarTrend identified an Uptrend for Cincinnati Financial (NASDAQ:CINF) on February 1st, 2016 at $57.61. In approximately 5 months, Cincinnati Financial has returned 25.62% as of today's recent price of $72.37.
CINF: 75.70 (+0.73)

Intercontinental Exchange Upgrades, Expands Data Services
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 9:56AM CDT
Intercontinental Exchange, Inc. (ICE) recently unveiled the expanded ICE Data Services.
CINF: 75.70 (+0.73), ICE: 256.89 (+2.93), BATS: 25.88 (+0.72), MKL: 947.53 (+15.23)

CME Group Adds New Contracts to Agricultural Product Suite
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 9:19AM CDT
CME Group Inc. (CME) recently unveiled four new palm contracts, which will be added to its suite of agricultural products.
CME: 98.90 (+0.75), CINF: 75.70 (+0.73), BATS: 25.88 (+0.72), MKL: 947.53 (+15.23)

Will Volatile Interest Rates Limit CME Group's (CME) Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:08AM CDT
On Jun 23, 2016, we issued an updated research report on CME Group Inc. (CME).
CME: 98.90 (+0.75), CINF: 75.70 (+0.73), BATS: 25.88 (+0.72), MKL: 947.53 (+15.23)

XL Group to Change its Place of Incorporation to Bermuda
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:43AM CDT
XL Group plc (XL) will re-domesticate to Bermuda from Ireland as its shareholders have approved of the move.
CINF: 75.70 (+0.73), NGHC: 20.90 (+0.39), XL: 33.01 (+0.39), MKL: 947.53 (+15.23)

Chubb (CB) & its Subsidiaries See Rating Action by A.M. Best
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 7:01AM CDT
A.M. Best reiterated the financial strength rating of A++ (Superior) of most subsidiaries of Chubb Limited (CB). With this, the rating agency removed the subsidiaries from under review with negative implications.
CINF: 75.70 (+0.73), NGHC: 20.90 (+0.39), CB: 130.24 (+1.61), MKL: 947.53 (+15.23)

Progressive (PGR) May Earnings Fall, Revenues Improve
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:09AM CDT
Progressive's (PGR) operating earnings for May 2016 came in at 11 cents per share, down 15.4% from 13 cents earned in the year-ago month. Increase in expenses offset revenue improvement and resulted in earnings decline.
PGR: 33.69 (+0.55), CINF: 75.70 (+0.73), NGHC: 20.90 (+0.39), MKL: 947.53 (+15.23)

Zacks Investment Ideas feature highlights: Cincinnati Financial, Lowe's, Vanguard Dividend Appreciation ETF and Schwab U.S. Dividend Equity ETF
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 8:30AM CDT
Zacks Investment Ideas feature highlights: Cincinnati Financial, Lowe's, Vanguard Dividend Appreciation ETF and Schwab U.S. Dividend Equity ETF
CINF: 75.70 (+0.73), VIG: 84.49 (+1.19), LOW: 82.34 (+1.86), SCHD: 41.97 (+0.55)

High Quality Dividend Stocks & ETFs for Uncertain Markets
Neena Mishra - Zacks Investment Research - Mon Jun 13, 12:17PM CDT
In the current uncertain market environment, high quality dividend payers are likely to emerge as winners.
CINF: 75.70 (+0.73), VIG: 84.49 (+1.19), LOW: 82.34 (+1.86), SCHD: 41.97 (+0.55)

Progressive Poised for Growth Despite High Combined Ratio
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 9:28AM CDT
On Jun 10, 2016, we issued an updated research report on Progressive Corp. (PGR).
PGR: 33.69 (+0.55), CINF: 75.70 (+0.73), NMIH: 5.63 (+0.19), MKL: 947.53 (+15.23)

Cincinnati Financial Well Poised: Is it in Your Portfolio?
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:13AM CDT
On Jun 9, 2016, we issued an updated research report on Cincinnati Financial Corporation (CINF).
CINF: 75.70 (+0.73), NGHC: 20.90 (+0.39), NMIH: 5.63 (+0.19), MKL: 947.53 (+15.23)

Maiden Holdings (MHLD) Offers Senior Notes Worth $110M
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:56AM CDT
Maiden Holdings, Ltd. (MHLD) will offer 6.625% $110 million senior notes. These notes are scheduled to mature on Jun 14, 2046.
CINF: 75.70 (+0.73), MHLD: 12.07 (+0.14), NMIH: 5.63 (+0.19), MKL: 947.53 (+15.23)

XL Group Poised for Growth Despite Exposure to Cat Losses
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:49AM CDT
On Jun 7, 2016, we issued an updated research report on XL Group plc (XL).
CINF: 75.70 (+0.73), NMIH: 5.63 (+0.19), XL: 33.01 (+0.39), MKL: 947.53 (+15.23)

Cincinnati Financial (CINF) Hits 52-Week High on Strong Q1
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:19AM CDT
On Jun 6, 2016, shares of Cincinnati Financial Corp. (CINF) hit a 52-week high of $69.81, driven by better-than-expected first-quarter 2016 results.
CINF: 75.70 (+0.73), NGHC: 20.90 (+0.39), MKL: 947.53 (+15.23), MCO: 96.73 (+2.50)

Cincinnati Financial Has Returned 20.4% Since SmarTrend Recommendation (CINF)
Comtex SmarTrend(R) - Tue Jun 07, 1:07AM CDT
SmarTrend identified an Uptrend for Cincinnati Financial (NASDAQ:CINF) on February 1st, 2016 at $57.61. In approximately 4 months, Cincinnati Financial has returned 20.45% as of today's recent price of $69.39.
CINF: 75.70 (+0.73)

Intercontinental Exchange Weak Trading Volumes a Drag
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:16AM CDT
On Jun 1, 2016, we issued an updated research report on Intercontinental Exchange, Inc. (ICE).
CINF: 75.70 (+0.73), ICE: 256.89 (+2.93), NMIH: 5.63 (+0.19), MKL: 947.53 (+15.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CMC Declares Dividend Amid Complex Outlook

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Quark Baby's Milk Warmer Debut at Vancouver & Dubai

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Navigating Battery Compliance for AI Data Centers

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Paradigm Therapeutics: A Beacon in Rare Diseases

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...